Artificial-intelligence-enabled digital stethoscope improves point-of-care screening for moderate-to-severe valvular heart disease.

Moshe Rancier¹, Igor Israel², Vimalson Monickam², Caroline Currie³, Ben Verschoore³, Emileigh Lastowski³, Douglas W Van Pelt³, John Prince³, Rosalie V McDonough³

¹Adult Primary Care, Mass General Brigham Community Physicians, Lawrence, MA, USA.

²Medicine, Parker Jewish Institute for Health Care and Rehabilitation, New Hyde Park, NY, USA.

³Eko Health, Inc. 2100 Powell Street, Ste. 300, Emeryville, CA 94608, USA.

PubMed PMC DOI PDF

Abstract

AIMS: Valvular heart disease (VHD) can affect more than one in two adults over 65 yet remains underdiagnosed due to the limitations of traditional auscultation. Earlier detection is critical for improving outcomes, but many cases go unrecognized. This study evaluates whether an artificial intelligence (AI)-enabled digital stethoscope can augment primary care providers' (PCPs) ability to detect cli…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.